Australia's largest stock trading and investment forum Australia's #1 stock forum

PER

Click for more information

0.00%

8.2¢ percheron therapeutics limited

Ann: Antisense Therapeutics Corporate Presentation, page-65

First 65 Last

Share
Profile

Follow
P3COrion

181 Posts.

68

31/08/23

10:21

Post #: 69656102
Share

Originally posted by waynesworld: ↑

Here's a question. If the FDA grants accelerated approval for a drug that has been granted Rare Pediatric Disease Designation when does the drug company become eligible for the pediatric Priority Review Voucher? Is it straightaway or after the successful conclusion of the Post-Approval Commitment?

It appears that the answer is straightaway. For instance, Sarepta who received accelerated approval for SRP-9001 in June 2023 sold its PRV for US$102m in July 2023.

Following the recent placement and SPP, ANP has a cash runway to Q2 2024 with the potential prospect of an accelerated approval pathway from the Phase IIb study. We can all produce our own timeline but the numbers appear to add up with ANP holding 100% of the rights to ATL1102 post approval. It makes the comparison with NEU all the more interesting particularly in regards to the potential impact upon market capitalisation.

Expand

If this is correct, and ANP are successful in that timeline, it would be a masterstroke. What an achievement that would be. It would certainly put to bed all the noise around capital management and shareholder value we are unduly bombarded with on here.

ANP Price at posting: 6.1¢ Sentiment: Buy Disclosure: Held
16 Upvote

5 Great analysis

Reply

Top Stories

CC9

Chariot locks in high-potential drill target at Black Mountain, one of the USA's largest lithium landholdings

Why are so many ASX explorers setting up shop in Saudi Arabia? + 8 stocks to watch

Week 34 Wrap: HotCopper's top watched; Oz banks cut saver interest; Kamala’s 28% corporate tax; AI’s back

The Rising Tide: How institutional adoption is shaping the future of crypto

SER

How flooding did Strategic Energy Resources a favour: Four holes down in 'redesigned' gold & copper campaign

There are more pages in this discussion • 18 more messages in this thread...

First 65 Last

Add PER (ASX) to my watchlist

(20min delay)
Last 8.2¢		Change 0.000(0.00%)		Mkt cap ! $73.92M

Open	High	Low	Value	Volume
8.0¢	8.2¢	8.0¢	$29.39K	366.3K

Buyers (Bids)

No.	Vol.	Price($)
1	6275	8.0¢

Sellers (Offers)

Price($)	Vol.	No.
8.2¢	242816	1

View Market Depth

No.	Vol.	Price($)
1	6275	0.080
1	42922	0.079
2	30620	0.078
1	10000	0.077
1	26000	0.076

Price($)	Vol.	No.
0.082	242816	1
0.083	100000	1
0.084	100250	1
0.085	100000	1
0.086	291111	3

Last trade - 16.10pm 27/08/2024 (20 minute delay)

PER (ASX) Chart

SPONSORED BY